Hisamitsu Pharmaceutical Co (TSE:4530) Gross-Profit-to-Asset % : 23.50% (As of Nov. 2023)

View and export this data going back to 1962. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Hisamitsu Pharmaceutical Co's annualized Gross Profit for the quarter that ended in Nov. 2023 was 円79,816 Mil. Hisamitsu Pharmaceutical Co's average Total Assets over the quarter that ended in Nov. 2023 was 円339,605 Mil. Therefore, Hisamitsu Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Nov. 2023 was 23.50%.

Hisamitsu Pharmaceutical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Gross-Profit-to-Asset % Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

29.05

22.78

23.25

23.57

24.57

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															24.48	23.62	23.99	23.50	24.55

Competitive Comparison of Hisamitsu Pharmaceutical Co's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hisamitsu Pharmaceutical Co's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's Gross-Profit-to-Asset % falls into.

Hisamitsu Pharmaceutical Co Gross-Profit-to-Asset % Calculation

Hisamitsu Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Feb. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Feb. 2024 )	/	( (Total Assets (A: Feb. 2023 )	+	Total Assets (A: Feb. 2024 ))	/ count )
	=	78970	/	( (313917	+	328779)	/ 2 )
	=	78970	/	321348
	=	24.57 %

Hisamitsu Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Nov. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Nov. 2023 )	/	( (Total Assets (Q: Aug. 2023 )	+	Total Assets (Q: Nov. 2023 ))	/ count )
	=	79816	/	( (344300	+	334909)	/ 2 )
	=	79816	/	339604.5
	=	23.50 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Nov. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Hisamitsu Pharmaceutical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (TSE:4530) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

HPX:Germany

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (TSE:4530) Headlines

No Headlines